‘Doxorubicin and MBO-asGCS Oligonucleotide Loaded Lipid Nanoparticles Overcome Multidrug Resistance in Adriamycin Resistant Ovarian Cancer Cells (NCI/ADR-RES)

The objective of this study was to increase the potency of doxorubicin against adriamycin-resistant NCI/ADR-RES cells by concurrent treatment with doxorubicin and MBO-asGCS loaded solid-lipid nanoparticles (SLN). Loading doxorubicin as ion-pair complex with deoxytaurocholate into cationic and neutra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Siddiqui, Akhtar, Gupta, Vineet, Liu, Yong-Yu, Nazzal, Sami
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3358787/
https://ncbi.nlm.nih.gov/pubmed/22562053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2012.04.050
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak